𝟐𝟎𝟐𝟐 𝐍𝐈𝐇 𝐒𝐭𝐮𝐝𝐲 𝐅𝐢𝐧𝐝𝐬 𝐍𝐨 𝐋𝐢𝐧𝐤 𝐁𝐞𝐭𝐰𝐞𝐞𝐧 𝐕𝐚𝐩𝐢𝐧𝐠 𝐚𝐧𝐝 𝐂𝐚𝐫𝐝𝐢𝐨𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 𝐀𝐦𝐨𝐧𝐠𝐬𝐭 𝐏𝐚𝐫𝐭𝐢𝐜𝐢𝐩𝐚𝐧𝐭𝐬
In a 2022 study at the National Institute of Health, participants who exclusively used vapor products showed no difference in Cardiovascular Disease (CVD) Risk compared to that of non-users of vapor products or tobacco.
"In a 2022 study funded in part by the National Institutes of Health (NIH), Berlowitz et al. conducted a longitudinal analysis based on self-reported data from roughly 24,000 adult participants (50% of whom were younger than 35 years) in the national PATH (Population Assessment of Tobacco and Health) study to examine the link between e-cigarette use and incident CVD.
After adjusting for covariates including demographic factors, comorbidities, and smoking history, analyses showed no difference in CVD risk between exclusive e-cigarette users and nonusers of combustible cigarettes or e-cigarettes (hazard ratio [HR], 1.00; 95% CI, 0.69-1.45) in up to 4 years of follow-up.
In addition, the results revealed a 30% to 40% lower risk for the outcome of “any CVD” in association with e-cigarette users compared with combustible cigarette users."